The Orexin Receptor market is a subset of the Central Nervous System Drugs market. It is composed of drugs that target the Orexin Receptor, a protein found in the brain that is involved in the regulation of sleep and wakefulness. Orexin Receptor agonists are used to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness. Orexin Receptor antagonists are used to treat insomnia, a sleep disorder characterized by difficulty falling asleep or staying asleep. The Orexin Receptor market is a rapidly growing segment of the Central Nervous System Drugs market. It is expected to experience strong growth in the coming years due to the increasing prevalence of sleep disorders and the development of new drugs targeting the Orexin Receptor. Some companies in the Orexin Receptor market include Merck, Pfizer, GlaxoSmithKline, Sanofi, and Takeda. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
